Streamlined Hyperacute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator–Eligible Stroke Patients When Clinical Impression Is Stroke Mimic | Zendy

Manu S. Goyal | Zendy; Brian Hoff | Zendy; Jennifer Williams | Zendy; Naïm Khoury | Zendy; Rebecca Wiesehan | Zendy; Laura Heitsch | Zendy; Peter D. Panagos | Zendy; Katie D. Vo | Zendy; Tammie L.S. Benzinger | Zendy; Colin P. Derdeyn | Zendy; JinMoo Lee | Zendy; Andria L. Ford | Zendy

Open Access

Streamlined Hyperacute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator–Eligible Stroke Patients When Clinical Impression Is Stroke Mimic

Author(s) -

Manu S. Goyal,

Brian Hoff,

Jennifer Williams,

Naïm Khoury,

Rebecca Wiesehan,

Laura Heitsch,

Peter D. Panagos,

Katie D. Vo,

Tammie L.S. Benzinger,

Colin P. Derdeyn,

JinMoo Lee,

Andria L. Ford

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.011913

Subject(s) - medicine , magnetic resonance imaging , tissue plasminogen activator , stroke (engine) , radiology , surgery , mechanical engineering , engineering

Stroke mimics (SM) challenge the initial assessment of patients presenting with possible acute ischemic stroke (AIS). When SM is considered likely, intravenous tissue-type plasminogen activator (tPA) may be withheld, risking an opportunity to treat AIS. Although computed tomography is routinely used for tPA decision making, magnetic resonance imaging (MRI) may diagnose AIS when SM is favored but not certain. We hypothesized that a hyperacute MRI (hMRI) protocol would identify tPA-eligible AIS patients among those initially favored to have SM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research